ReviewBioelectricity2025
Meeting Review: "National Cancer Institute Conference on Cancer Bioelectricity" September 12, 2024.
Review in Bioelectricity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Office of Cancer Complementary and Alternative Medicine, part of the Division of Cancer Treatment and Diagnosis under the National Cancer Institute (NCI), supports research in diverse areas of cancer therapeutics such as microbial therapies, herbal remedies, and mind-body practices. Recently they have become especially interested in the emerging role of bioelectricity in cancer biology and organized a virtual meeting with some of the top scientists in the field. In this report, we overview this first-of-its-kind Naional Institute of Health (NIH)-sponsored meeting, which featured talks from 14 researchers exploring the role of bioelectricity in cancer biology. The talks covered a wide range of topics, including excellent background information on how cell collectives change their bioelectrical coupling and set points during cancer formation, new tools for reading and writing bioelectrical signatures in cells and whole organisms, how ion channels that are involved in setting those signatures affect canonical pathways in development and tumor growth, and the methods for modeling bioelectrical interactions and information transfer in cell collectives. Especially exciting were the translational technologies that were highlighted, including new diagnostics, metastasis inhibition therapies, and more efficient detection of surgical margins. The meeting concluded with funding opportunities available from the NCI Division of Cancer Biology, Innovative Molecular Analysis Technologies Program, and the Small Business Innovation Research Development Center.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.